ARTICLE | Company News
NanoCarrier, Orient Europharma deal
September 30, 2013 7:00 AM UTC
NanoCarrier and Orient signed a memorandum of understanding (MOU) to amend an October 2008 deal granting Orient rights to NanoCarrier's Nanoplatin. Under the MOU, Phase III trials to evaluate Nanopla...